XML 44 R23.htm IDEA: XBRL DOCUMENT v3.3.0.814
DERIVATIVE LIABILITIES (Tables)
9 Months Ended
Sep. 30, 2015
DERIVATIVE LIABILITY [Line Items]  
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
 
The table below sets forth a summary of changes in the fair value of the Company’s Level 3 derivative liabilities associated with the August 2015 underwritten offering for the nine months ended September 30, 2015:
 
 
 
Series A
 
Series B
 
Series C
 
Series D
 
Total
 
Balance at January 1, 2015
 
$
 
$
 
$
 
$
 
$
 
Recognition of warrant liability on issuance date
 
 
1,275,000
 
 
1,568,000
 
 
178,000
 
 
347,000
 
 
3,368,000
 
Reclassification of derivative liability to stockholders’ equity upon exercise
 
 
 
 
(1,197,000)
 
 
 
 
 
 
(1,197,000)
 
Change in fair value of derivative liabilities
 
 
(151,000)
 
 
(371,000)
 
 
(101,000)
 
 
(198,000)
 
 
(821,000)
 
Balance at September 30, 2015
 
$
1,124,000
 
$
 
$
77,000
 
$
149,000
 
$
1,350,000
 
Schedule of Derivative Liabilities at Fair Value [Table Text Block]
The following are the key assumptions used in connection with the valuation of the warrants exercisable into common stock on the date of issuance and September 30, 2015:
 
 
 
Series A
 
Series B
 
Series C
 
Series D
 
Date of warrant
 
 
8/19/2015
 
 
8/19/2015
 
 
8/19/2015
 
 
8/19/2015
 
Number of shares underlying the warrants
 
 
2,500,000
 
 
2,450,000
 
 
2,550,000
 
 
4,950,000
 
Fair market value of stock
 
$
0.65
 
$
0.65
 
$
0.65
 
$
0.65
 
Exercise price
 
$
1.00
 
$
0.01
 
$
1.00
 
$
0.99
 
Volatility
 
 
121.4
%
 
121.4
%
 
125.4
%
 
125.4
%
Risk-free interest rate
 
 
1.03
%
 
1.03
%
 
0.30
%
 
0.30
%
Expected dividend yield
 
 
 
 
 
 
 
 
 
Warrant life (years)
 
 
5
 
 
5
 
 
0.25
 
 
0.25
 
 
 
 
Series A
 
Series B
 
Series C
 
Series D
 
Number of shares underlying the warrants on September 30, 2015
 
 
2,500,000
 
 
 
 
2,550,000
 
 
4,950,000
 
Fair market value of stock
 
$
0.58
 
 
 
$
0.58
 
$
0.58
 
Exercise price
 
$
1.00
 
 
 
$
1.00
 
$
0.99
 
Volatility
 
 
124.2
%
 
 
 
144.4
%
 
144.4
%
Risk-free interest rate
 
 
0.98
%
 
 
 
0.38
%
 
0.38
%
Expected dividend yield
 
 
 
 
 
 
 
 
 
Warrant life (years)
 
 
4.88
 
 
 
 
0.13
 
 
0.13
 
Derivative Financial Instruments, Liabilities [Member]  
DERIVATIVE LIABILITY [Line Items]  
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The following table sets forth a summary of the changes in the fair value of our Level 3 financial liabilities that are measured at fair value on a recurring basis:
 
 
 
Three Months Ended
 
Nine Months Ended
 
 
 
September 30,
 
September 30,
 
 
 
2015
 
2014
 
2015
 
2014
 
Beginning balance
 
$
320,000
 
$
-
 
$
270,000
 
$
-
 
Recognition of conversion feature liability
 
 
-
 
 
-
 
 
769,000
 
 
-
 
Recognition of warrant liability on issuance date
 
 
3,368,000
 
 
-
 
 
3,783,000
 
 
-
 
Reclassification to stockholders’ equity upon exercise
 
 
(1,196,000)
 
 
-
 
 
(1,866,000)
 
 
-
 
Change in fair value of derivative liabilities
 
 
(1,103,000)
 
 
-
 
 
(1,567,000)
 
 
-
 
Ending balance
 
$
1,389,000
 
$
-
 
$
1,389,000
 
$
-
 
Schedule of Derivative Liabilities at Fair Value [Table Text Block]
The following are the key assumptions used in connection with the valuation of the conversion options associated with the Series A Financing, Series B Financing, and Series C Financing on the date of issuance, at December 31, 2014 and September 30, 2015:
 
 
 
Series A
 
 
Series B
 
 
Series B
 
 
Series C
 
 
 
Financing
 
 
Financing
 
 
(Related Party)
 
 
Financing
 
Date of issuance
 
 
12/31/2014
 
 
 
2/11/2015
 
 
 
2/24/2015
 
 
 
2/24/2015
 
Number of shares convertible into
 
 
750,000
 
 
 
350,000
 
 
 
845,000
 
 
 
1,800,000
 
Fair market value of stock
 
$
5.10
 
 
$
4.22
 
 
$
4.50
 
 
$
4.50
 
Conversion price
 
$
5.70
 
 
$
3.57
 
 
$
4.00
 
 
$
4.00
 
Volatility
 
 
131
%
 
 
143.4
%
 
 
143.4
%
 
 
143.4
%
Risk-free interest rate
 
 
0.25
%
 
 
0.24
%
 
 
0.22
%
 
 
0.22
%
Expected dividend yield
 
 
7
%
 
 
7
%
 
 
7
%
 
 
7
%
Life of convertible preferred stock (years)
 
 
1
 
 
 
1
 
 
 
1
 
 
 
1
 
Preferred Stock [Member]  
DERIVATIVE LIABILITY [Line Items]  
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
The table below sets forth a summary of changes in the fair value of the Company’s Level 3 derivative liabilities associated with the Series A Financing, Series B Financing, and Series C Financing for the nine months ended September 30, 2015:
 
 
 
Series A
 
 
Series B
 
 
Series B
 
 
Series C
 
 
 
 
 
 
Financing
 
 
Financing
 
 
(Related Party)
 
 
Financing
 
 
Total
 
Balance at January 1, 2015
 
$
270,000
 
 
$
 
 
$
 
 
$
 
 
$
270,000
 
Recognition of conversion feature liability
 
 
 
 
 
81,000
 
 
 
220,000
 
 
 
468,000
 
 
 
769,000
 
Recognition of warrant derivative liability
 
 
 
 
 
45,000
 
 
 
118,000
 
 
 
252,000
 
 
 
415,000
 
Reclassification to stockholders’ equity upon conversion
 
 
(150,000)
 
 
 
(54,000)
 
 
 
(220,000)
 
 
 
(245,000)
 
 
 
(669,000)
 
Change in fair value of derivative liabilities
 
 
(111,000)
 
 
 
(69,000)
 
 
 
(111,000)
 
 
 
(455,000)
 
 
 
(746,000)
 
Balance at September 30, 2015
 
$
9,000
 
 
$
3,000
 
 
$
7,000
 
 
$
20,000
 
 
$
39,000
 
Warrant [Member]  
DERIVATIVE LIABILITY [Line Items]  
Schedule of Derivative Liabilities at Fair Value [Table Text Block]
The following are the key assumptions used in connection with the valuation of the warrants associated with the Series A Financing, Series B Financing, and Series C Financing at December 31, 2014, their respective issuance dates, and September 30, 2015:
 
 
 
Series A
 
 
Series B
 
 
Series B
 
 
Series C
 
 
 
Financing
 
 
Financing
 
 
(Related Party)
 
 
Financing
 
Date of warrant
 
 
12/31/2014
 
 
 
2/11/2015
 
 
 
2/24/2015
 
 
 
2/24/2015
 
Number of shares underlying the warrants
 
 
37,500
 
 
 
17,500
 
 
 
42,250
 
 
 
90,000
 
Fair market value of stock
 
$
5.10
 
 
$
4.22
 
 
$
4.50
 
 
$
4.50
 
Exercise price
 
$
20.00
 
 
$
20.00
 
 
$
20.00
 
 
$
20.00
 
Volatility
 
 
112.9
%
 
 
120.6
%
 
 
115.8
%
 
 
115.8
%
Risk-free interest rate
 
 
0.96
%
 
 
0.90
%
 
 
0.90
%
 
 
0.90
%
Expected dividend yield
 
 
 
 
 
 
 
 
 
 
 
 
Warrant life (years)
 
 
5
 
 
 
5
 
 
 
5
 
 
 
5
 
  
 
 
Series A
 
 
Series B
 
 
Series B
 
 
Series C
 
 
 
Financing
 
 
Financing
 
 
(Related Party)
 
 
Financing
 
Number of shares underlying the warrants on September 30, 2015
 
 
37,500
 
 
 
17,500
 
 
 
42,250
 
 
 
90,000
 
Fair market value of stock
 
$
0.58
 
 
$
0.58
 
 
$
0.58
 
 
$
0.58
 
Exercise price
 
$
11.50
 
 
$
11.50
 
 
$
20.00
 
 
$
11.50
 
Volatility
 
 
119.9
%
 
 
119.7
%
 
 
119.5
%
 
 
119.5
%
Risk-free interest rate
 
 
1.03
%
 
 
1.03
%
 
 
1.03
%
 
 
1.03
%
Expected dividend yield
 
 
 
 
 
 
 
 
 
 
 
 
Warrant life (years)
 
 
4.25
 
 
 
4.35
 
 
 
4.40
 
 
 
4.40